Sophie Leclerc
- Molecular Biology top 5%
- Oncology top 2%
- Organic Chemistry top 2%
- Cell Biology top 2%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Laurent MeijerLibor Havlı́čekWalter Filgueira de AzevedoDoris MarkoGerhard EisenbrandJaroslav VeselýMiroslav StrnadMaryse Leost
- Topics
- Cancer-related Molecular Pathways (9 papers)Microtubule and mitosis dynamics (6 papers)Biochemical and Molecular Research (4 papers)
- Cited by
- OncologyToxicologyCell Biology
- Partner nations
- FranceUnited StatesCzechia
In The Last Decade
Sophie Leclerc
19 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 2.3k
- Oncology 1.3k
- Organic Chemistry 1.1k
- Cell Biology 615
- Pulmonary and Respiratory Medicine 304
Countries citing papers authored by Sophie Leclerc
This map shows the geographic impact of Sophie Leclerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Leclerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Leclerc more than expected).
Fields of papers citing papers by Sophie Leclerc
This network shows the impact of papers produced by Sophie Leclerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Leclerc. The network helps show where Sophie Leclerc may publish in the future.
Co-authorship network of co-authors of Sophie Leclerc
This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Leclerc. A scholar is included among the top collaborators of Sophie Leclerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Leclerc. Sophie Leclerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 42 | |
| 3 | 14 | |
| 4 | 36 | |
| 5 | Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Diseasebreakdown → | 635 |
| 6 | 47 | |
| 7 | 8 | |
| 8 | 53 | |
| 9 | 3 | |
| 10 | Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinasesbreakdown → | 682 |
| 11 | 72 | |
| 12 | 84 | |
| 13 | 7 | |
| 14 | Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitorsbreakdown → | 676 |
| 15 | 43 | |
| 16 | Inhibition of Cyclin‐Dependent Kinases by Purine Analoguesbreakdown → | 619 |
| 17 | 208 | |
| 18 | 19 | |
| 19 | Inhibition of Cyclin‐Dependent Kinases by Purine Analoguesbreakdown → | 562 |
About Sophie Leclerc
Sophie Leclerc is a scholar working on Cell Biology, Oncology and Toxicology, having authored 19 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Microtubule and mitosis dynamics (6 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Oncology (1.3k citations), Toxicology (133 citations) and Cell Biology (615 citations). Sophie Leclerc has collaborated with scholars based in France, United States and Czechia. Frequent co-authors include Laurent Meijer, Libor Havlı́ček, Walter Filgueira de Azevedo, Doris Marko, Gerhard Eisenbrand, Jaroslav Veselý, Miroslav Strnad, Maryse Leost, Nathanael S. Gray and Peter G. Schultz. Their work appears in journals such as Science, Journal of Biological Chemistry and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.